Alpha Tau Medical (DRTSW) Accumulated Expenses (2021 - 2026)
Alpha Tau Medical (DRTSW) posted Accumulated Expenses of $5.5 million for Q4 2025, up 17.72% sequentially from $4.7 million in Q2 2025, and up 33.27% YoY from $4.1 million in Q4 2024.
Alpha Tau Medical (DRTSW) Accumulated Expenses (2021 - 2026) Analysis & Trends
Alpha Tau Medical has reported Accumulated Expenses for 5 years, with the latest figure at $5.5 million in Q4 2025.
- Quarterly Accumulated Expenses rose 33.27% year-over-year to $5.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.5 million (up 33.27% YoY) and the FY2025 annual result came in at $5.5 million, up 33.27% from the prior year.
- Accumulated Expenses advanced to $5.5 million in Q4 2025 per DRTSW's latest filing, from $4.7 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $5.5 million in Q4 2025 and troughed at $2.2 million in Q4 2022.
- A 5-year average of $3.7 million and a median of $3.4 million in 2023 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2023: Accumulated Expenses fell 29.86% in 2022, then surged 54.67% in 2023.
- Over 5 years, Accumulated Expenses stood at $3.2 million in 2021, then retreated by 29.86% to $2.2 million in 2022, then soared by 54.67% to $3.5 million in 2023, then gained by 18.97% to $4.1 million in 2024, then jumped by 33.27% to $5.5 million in 2025.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $5.5 million, $4.7 million, and $4.1 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Alpha Tau Medical | 383.00 Mn | 200.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.15 Mn |
| Mar 31, 2026 | 5.53 Mn |
| Dec 31, 2025 | 5.51 Mn |
| Jun 30, 2025 | 4.68 Mn |
| Dec 31, 2024 | 4.13 Mn |
| Jun 30, 2024 | 3.41 Mn |
| Dec 31, 2023 | 3.47 Mn |
| Jun 30, 2023 | 2.78 Mn |
| Dec 31, 2022 | 2.25 Mn |
| Dec 31, 2021 | 3.20 Mn |